Загрузка...
BRCAness as an Important Prognostic Marker in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy: A Multicenter Retrospective Study
Triple-negative breast cancer (TNBC) has several subtypes. The identification of markers associated with recurrence and poor prognosis in patients with TNBC is urgently needed. BRCAness is a set of traits in which BRCA1 dysfunction, arising from gene mutation, methylation, or deletion, results in DN...
Сохранить в:
| Опубликовано в: : | Diagnostics (Basel) |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7168149/ https://ncbi.nlm.nih.gov/pubmed/32098267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10020119 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|